A detailed history of True Wealth Design, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, True Wealth Design, LLC holds 353 shares of HRMY stock, worth $12,012. This represents 0.0% of its overall portfolio holdings.

Number of Shares
353
Previous 71 397.18%
Holding current value
$12,012
Previous $1.96 Million 575.01%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 08, 2026

BUY
$25.9 - $34.29 $7,303 - $9,669
282 Added 397.18%
353 $13.2 Million
Q3 2025

Oct 21, 2025

BUY
$26.76 - $38.05 $1,899 - $2,701
71 New
71 $1.96 Million
Q1 2025

May 13, 2025

BUY
$32.18 - $40.46 $225 - $283
7 Added 41.18%
24 $797,000
Q4 2024

Feb 14, 2025

SELL
$31.86 - $41.49 $1,274 - $1,659
-40 Reduced 70.18%
17 $585,000
Q3 2024

Nov 14, 2024

BUY
$30.0 - $39.95 $1,710 - $2,277
57 New
57 $2.28 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.01B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track True Wealth Design, LLC Portfolio

Follow True Wealth Design, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Wealth Design, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Wealth Design, LLC with notifications on news.